Vimarsana
Biggest News Aggregation in the World

Page 2 - Proffered Paper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proffered Paper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proffered Paper Today - Breaking & Trending Today

Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease - Vimarsana News

Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease

First Phase 3 survival data from KEYNOTE-A39/EV-302 support potential benefit of combination approach in previously untreated locally advanced or metastatic urothelial cancer; data are selected for...

Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer - Vimarsana News

Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer

Key data from the Phase III PSMAfore trial has been selected for a Presidential session; PSMAfore is investigating PluvictoTM vipivotide tetraxetan) in the pre-chemotherapy setting for patients with...

Mirati To Present Updated Clinical Data at ESMO Congress 2023 - Vimarsana News

Mirati To Present Updated Clinical Data at ESMO Congress 2023

/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage research and development biotechnology company, today announced several...

Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference - Vimarsana News

Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference

/PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, is pleased to announce today that the company will...

THE MENARINI GROUP AND ITS SUBSIDIARY STEMLINE THERAPEUTICS: Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting - Vimarsana News

THE MENARINI GROUP AND ITS SUBSIDIARY STEMLINE THERAPEUTICS: Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics ("Stemline"), a wholly-owned subsidiary of the Menarini Group, announced today that